RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y

Rigetti Computing (RGTI) reported a mixed Q2 2025, with an adjusted loss per share of 5 cents beating estimates, but revenue declining 41.6% year-over-year to $1.8 million, missing consensus. The significant revenue drop, attributed partly to the expiration of the U.S. National Quantum Initiative, led to a 3310 basis point gross margin contraction and increased operating loss. Despite these financial headwinds, RGTI launched Cepheus-1-36Q, its largest multi-chip quantum computer with 99.5% fidelity, reinforcing its chiplet-based scaling strategy, and maintains a strong balance sheet with $425.7 million in cash and no debt.

Analysis

Rigetti Computing (RGTI) presents a stark contrast between deteriorating near-term financials and significant long-term technological progress. The company's second-quarter 2025 results were marked by a severe 41.6% year-over-year revenue decline to $1.8 million, missing consensus estimates by 5.7%. This top-line erosion, attributed to the expiration of the U.S. National Quantum Initiative, directly led to a dramatic 3,310 basis point contraction in gross margin to 31.4% and a wider operating loss of $19.9 million. Despite a narrower adjusted loss per share of 5 cents, the underlying financial trends are negative, reflected in the stock's 3% year-to-date gain, which substantially lags the industry's 20.5% growth. Juxtaposing these financial headwinds is the successful launch of its Cepheus-1-36Q system, the industry's largest multi-chip quantum computer, which boasts a 99.5% median two-qubit gate fidelity—a twofold reduction in error rates. This technical achievement, coupled with a robust balance sheet featuring $425.7 million in cash and zero debt, provides a critical runway for continued R&D but underscores the company's current pre-commercialization risk profile.

Key Decisions for Investors

• Investors should closely monitor developments regarding the reauthorization of the U.S. National Quantum Initiative, as management has identified this as a critical catalyst for revenue recovery.
• The core investment thesis hinges on betting on long-term technological leadership against immediate financial weakness; therefore, one should weigh the significance of the Cepheus-1-36Q launch and its improved fidelity against the sharp revenue decline and margin compression.
• While the $425.7 million cash position provides a substantial buffer, the quarterly operating cash burn of $29.8 million should be tracked to assess the company's operational runway in the absence of revenue growth.
• Given the stock's significant underperformance relative to its peers, initiating or adding to a position should be viewed as a speculative play on the company's ability to translate its technological milestones into commercial contracts and reverse its negative financial trends.